Document is current
Any future updates will be listed below
-
Authors
Bachand, Jacqueline
Soulos, Pamela R.
Herrin, Jeph
Pollack, Craig E.
Xu, Xiao
Ma, Xiaomei
Gross, Cary P. https://orcid.org/0000-0002-4974-935X
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA190017)
- License Information
-
More Information
Article History
Received: 26 March 2018
Accepted: 13 April 2018
First Online: 24 April 2018
Compliance with ethical standards
:
: Ms. Soulos and Dr. Gross receive research funding from twenty-first Century Oncology LLC. Dr. Pollack has stock ownership in Gilead Pharmaceuticals. Dr. Ma served as a consultant for Celgene and Incyte. Dr. Gross has also received research funding from NCCN-Pfizer and from Johnson & Johnson to help develop new approaches for sharing clinical trial data. The authors report no other relationships or activities that could appear to have influenced the submitted work.
